Evidence map›Paper›PMID 34689085›Full record

ArticleEBioMedicine2021

Somatosensory dysfunction is masked by variable cognitive deficits across patients on the Alzheimer's disease spectrum.

Alex I Wiesman, Victoria M Mundorf, Chloe C Casagrande, Sara L Wolfson, Craig M Johnson, Pamela E May, Daniel L Murman, Tony W Wilson

Abstract read
In one paragraph

Article in EBioMedicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. High-caloric intake rescues early symptomatic AD-induced hippocampal neurovascular coupling deficits.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Alex I WiesmanMcConnell Brain Imaging Centre, Montreal Neurological Institute, McGill University, 845 Sherbrooke St W, Montreal, QC H3A 0G4, Canada; Department of Neurological Sciences, University of Nebraska Medical Center (UNMC), Omaha, NE, USA. Electronic address: alexander.wiesman@mail.mcgill.ca.
Victoria M MundorfCenter for Brain, Biology, and Behavior, University of Nebraska - Lincoln, Lincoln, NE, USA.
Chloe C CasagrandeInstitute for Human Neuroscience, Boys Town National Research Hospital, Boys Town, NE, USA.
Sara L WolfsonGeriatrics Medicine Clinic, UNMC, Omaha, NE, USA.
Craig M JohnsonDepartment of Radiology, UNMC, Omaha, NE, USA.
Pamela E MayDepartment of Neurological Sciences, University of Nebraska Medical Center (UNMC), Omaha, NE, USA.
Daniel L MurmanDepartment of Neurological Sciences, University of Nebraska Medical Center (UNMC), Omaha, NE, USA; Memory Disorders and Behavioral Neurology Program, UNMC, Omaha, NE, USA.
Tony W WilsonInstitute for Human Neuroscience, Boys Town National Research Hospital, Boys Town, NE, USA.

Funding

MULTIMODAL IMAGING OF NEUROHIV DYNAMICS (MIND): AN OMAHA-PITTSBURGH CONSORTIUMR01MH118013 · NIMH · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI WILSON, TONY W · 2018 to 2022
$4.9M
SIGNATURES OF CANNABIS ABUSE IN NEUROHIV (SCAN): AN INTEGRATED MOLECULAR AND IMAGING APPROACHR01DA047828 · NIDA · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI BECKER, JAMES T., FOX, HOWARD S · 2018 to 2022
$4.5M
THE PROGRESSIVE ELEVATION OF SPONTANEOUS CORTICAL ACTIVITY IN HAND (PESCAH) PROJECTR01MH116782 · NIMH · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI WILSON, TONY W · 2018 to 2022
$3.4M
THE IMPACT OF SPONTANEOUS CORTICAL ACTIVITY ON NEURAL OSCILLATIONS AND BEHAVIORAL PERFORMANCE: EVIDENCE FROM HIGH-DEFINITION TDCS AND MEGRF1MH117032 · NIMH · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI WILSON, TONY W · 2018 to 2018
$2.4M
Characterizing the interaction between neural attention and somato-motor systems in non-demented patients with Parkinson's diseaseF32NS119375 · NINDS · MCGILL UNIVERSITY · PI WIESMAN, ALEX I · 2020 to 2023
$205k
Oscillatory markers of cognitive deficits in patients with Alzheimer's diseaseF31AG055332 · NIA · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI WIESMAN, ALEX I · 2017 to 2019
$119k
NIA NIH HHS F31 AG055332NIDA NIH HHS R01 DA047828NIMH NIH HHS R01 MH116782NIMH NIH HHS R01 MH118013NIMH NIH HHS RF1 MH117032NINDS NIH HHS F32 NS119375
6 · The paper itself

Abstract

backgroundAlzheimer's disease (AD) is generally thought to spare primary sensory function; however, such interpretations have drawn from a literature that has rarely taken into account the variable cognitive declines seen in patients with AD. As these cognitive domains are now known to modulate cortical somatosensory processing, it remains possible that abnormalities in somatosensory function in patients with AD have been suppressed by neuropsychological variability in previous research.

methodsIn this study, we combine magnetoencephalographic (MEG) brain imaging during a paired-pulse somatosensory gating task with an extensive battery of neuropsychological tests to investigate the influence of cognitive variability on estimated differences in somatosensory function between biomarker-confirmed patients on the AD spectrum and cognitively-normal older adults.

findingsWe show that patients on the AD spectrum exhibit largely non-significant differences in somatosensory function when cognitive variability is not considered (p-value range: .020-.842). However, once attention and processing speed abilities are considered, robust differences in gamma-frequency somatosensory response amplitude (p < .001) and gating (p = .004) emerge, accompanied by significant statistical suppression effects.

interpretationThese findings suggest that patients with AD exhibit insults to functional somatosensory processing in primary sensory cortices, but these effects are masked by variability in cognitive decline across individuals.

fundingNational Institutes of Health, USA; Fremont Area Alzheimer's Fund, USA.

Indexed as

AgedAged, 80 and overAlzheimer DiseaseAmyloid beta-PeptidesCognitionCognitive DysfunctionFemaleFluorodeoxyglucose F18Functional NeuroimagingHumansImage Processing, Computer-AssistedMagnetic Resonance ImagingMagnetoencephalographyMaleMiddle AgedNeuropsychological TestsAmyloid beta-PeptidesFluorodeoxyglucose F18Amyloid-βGamma oscillationsMagnetoencephalographyNeuropsychologySensory gating

Identifiers

PMID34689085
PMCPMC8550984

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.